Farallon Capital Partners, L.P.

13F Holdings History for Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)

Symbol: CRNX on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 5.63M shares
Security Ownership: 6%

Dapice Joshua J. ownership in Crinetics Pharmaceuticals, Inc. Common Stock (CRNX)

2025-09-08 - Dapice Joshua J. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.63M shares of Crinetics Pharmaceuticals, Inc. Common Stock (CRNX). This represents 6% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Dapice Joshua J.	6%		$165M	5.63M			$29.40	13G	8/29/2025	8 Sep 2025 17:36:35